The prevalence of pressure ulcers in the paediatric population

Laila Habiballah1, Ahmad Tubaishat2

  • 1Irbid National University, Department of Nursing, Irbid, Jordan.

Journal of Tissue Viability
|February 21, 2016
PubMed

Insights

Pediatric patients in Jordan experience pressure ulcers, with a prevalence of 6.6%. Most ulcers are device-related and occur in critical care units, highlighting the need for vigilant nursing care.

Area of Science:

  • Medical Research
  • Nursing Science
  • Patient Safety

Background:

  • Limited research exists on pediatric pressure ulcers, with varied reported prevalence rates.
  • Pressure ulcers pose a significant challenge in healthcare settings, particularly for vulnerable pediatric populations.

Purpose of the Study:

  • To determine the prevalence, location, and categories of pressure ulcers (PU) in inpatient pediatric wards.
  • To identify patient characteristics associated with pressure ulcers in a Jordanian hospital setting.

Main Methods:

  • A descriptive point prevalence study was conducted in two Jordanian hospitals.
  • 166 pediatric patients (1 day to 18 years) were assessed for pressure ulcers using the European Pressure Ulcer Advisory Panel classification.
  • Exclusion criteria included isolation, burn, emergency units, outpatient clinics, and psychiatric wards.

Main Results:

  • A prevalence rate of 6.6% for pressure ulcers was found, with 2.4% when Category I ulcers were excluded.
  • Most pressure ulcers (90.9%) were in critical care units, predominantly Category I (63.6%) and device-related (63.6%).
  • The face (54.5%) and occiput (18.2%) were the most common locations; affected patients were often male (54.5%) and under 12 months old (72.7%), with longer hospital stays.

Conclusions:

  • Pediatric patients in Jordan do develop pressure ulcers, with prevalence rates comparable to international findings.
  • Device-related pressure ulcers in critical care units are a significant concern.
  • Increased nursing vigilance is recommended for pediatric patients using medical devices to prevent pressure ulcers.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
693
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
27
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
458
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.0K